U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 44

1.
Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer’s disease
Xian-Le Bu, Pu-Yang Sun, Dong-Yu Fan, Jun Wang, Hao-Lun Sun, Yuan Cheng, Gui-Hua Zeng, Dong-Wan Chen, Hui-Yun Li, Xu Yi, Ying-Ying Shen, Luke A. Miles, Paul Maruff, Ben J. Gu, Christopher J. Fowler, Colin L. Masters, Yan-Jiang Wang
Sci Adv. 2022 Apr; 8(13): eabm5667. Published online 2022 Apr 1. doi: 10.1126/sciadv.abm5667
PMCID:
PMC10938586
AbstractArticlePDF–1018K
2.
Human CD22-Transgenic, Primary Murine Lymphoma Challenges Immunotherapies in Organ-Specific Tumor Microenvironments
Franziska Gsottberger, Carolin Brandl, Kerstin Wendland, Srdjan Petkovic, Charlotte Emmerich, Ramona Erber, Carol Geppert, Arndt Hartmann, Andreas Mackensen, Lars Nitschke, Fabian Müller
Int J Mol Sci. 2021 Oct; 22(19): 10433. Published online 2021 Sep 28. doi: 10.3390/ijms221910433
PMCID:
PMC8508822
AbstractArticlePDF–4.1M
3.
Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy
Senlian Hong, Chenhua Yu, Peng Wang, Yujie Shi, Weiqian Cao, Bo Cheng, Digantkumar G. Chapla, Yuanhui Ma, Jie Li, Emily Rodrigues, Yoshiki Narimatsu, John R. Yates, III, Xing Chen, Henrik Clausen, Kelly W. Moremen, Matthew Scott Macauley, James C. Paulson, Peng Wu
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2022 Feb 15.
Published in final edited form as: Angew Chem Int Ed Engl. 2021 Feb 15; 60(7): 3603–3610. Published online 2020 Dec 14. doi: 10.1002/anie.202005934
PMCID:
PMC7980786
AbstractArticlePDF–2.0M
4.
Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang, Xun Qi
Biosci Rep. 2018 Dec 21; 38(6): BSR20181423. Prepublished online 2018 Oct 24. Published online 2018 Nov 28. doi: 10.1042/BSR20181423
PMCID:
PMC6259014
AbstractArticlePDF–785K
5.
CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Delivers Toxins to B-Lymphoma Cells
Wenjie Peng, James C. Paulson
J Am Chem Soc. Author manuscript; available in PMC 2018 Sep 13.
Published in final edited form as: J Am Chem Soc. 2017 Sep 13; 139(36): 12450–12458. Published online 2017 Aug 31. doi: 10.1021/jacs.7b03208
PMCID:
PMC5755971
AbstractArticlePDF–1.3M
6.
Molecular basis of human CD22 function and therapeutic targeting
June Ereño-Orbea, Taylor Sicard, Hong Cui, Mohammad T. Mazhab-Jafari, Samir Benlekbir, Alba Guarné, John L. Rubinstein, Jean-Philippe Julien
Nat Commun. 2017; 8: 764. Published online 2017 Oct 2. doi: 10.1038/s41467-017-00836-6
PMCID:
PMC5624926
AbstractArticlePDF–1.7M
7.
Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt’s lymphoma (BL) Daudi cells by NMR spectroscopy
Paul D. Madge, Andrea Maggioni, Mauro Pascolutti, Moein Amin, Mario Waespy, Bernadette Bellette, Robin J. Thomson, Sørge Kelm, Mark von Itzstein, Thomas Haselhorst
Sci Rep. 2016; 6: 36012. Published online 2016 Nov 3. doi: 10.1038/srep36012
PMCID:
PMC5093622
AbstractArticlePDF–1.4M
8.
Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
Chien-Hsing Chang, Yang Wang, Pankaj Gupta, David M Goldenberg
MAbs. 2015 Jan-Feb; 7(1): 199–211. Published online 2014 Oct 30. doi: 10.4161/19420862.2014.979081
PMCID:
PMC4622945
AbstractArticlePDF–1.1M
9.
Novel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystem
Mengjiao Sun, Jun Wang, Qin Lu, Guohua Xia, Yu Zhang, Lina Song, Yongjun Fang
Drug Des Devel Ther. 2015; 9: 5123–5133. Published online 2015 Sep 7. doi: 10.2147/DDDT.S86764
PMCID:
PMC4567241
AbstractArticlePDF–2.8M
10.
Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
Robert J. Kreitman, Martin S. Tallman, Tadeusz Robak, Steven Coutre, Wyndham H. Wilson, Maryalice Stetler-Stevenson, David J. FitzGerald, Robert Lechleider, Ira Pastan
J Clin Oncol. 2012 May 20; 30(15): 1822–1828. Published online 2012 Feb 21. doi: 10.1200/JCO.2011.38.1756
PMCID:
PMC3383181
AbstractArticlePDF–194K
11.
Anti-CD22 Antibody Targeting of pH-responsive Micelles Enhances Small Interfering RNA Delivery and Gene Silencing in Lymphoma Cells
Maria C Palanca-Wessels, Anthony J Convertine, Richelle Cutler-Strom, Garrett C Booth, Fan Lee, Geoffrey Y Berguig, Patrick S Stayton, Oliver W Press
Mol Ther. 2011 Aug; 19(8): 1529–1537. Published online 2011 May 31. doi: 10.1038/mt.2011.104
PMCID:
PMC3149160
AbstractArticlePDF–427K
12.
CD22 Regulates Adaptive and Innate Immune Responses of B Cells
Norihito Kawasaki, Christoph Rademacher, James C. Paulson
J Innate Immun. 2011 Jun; 3(4): 411–419. Published online 2010 Dec 17. doi: 10.1159/000322375
PMCID:
PMC3130896
AbstractArticlePDF–317K
13.
CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia
Fatih M. Uckun, Patricia Goodman, Hong Ma, Ilker Dibirdik, Sanjive Qazi
Proc Natl Acad Sci U S A. 2010 Sep 28; 107(39): 16852–16857. Published online 2010 Sep 14. doi: 10.1073/pnas.1007896107
PMCID:
PMC2947921
AbstractArticlePDF–1.1M
14.
In Situ trans Ligands of CD22 Identified by Glycan-Protein Photocross-linking-enabled Proteomics
T. N. C. Ramya, Eranthie Weerapana, Lujian Liao, Ying Zeng, Hiroaki Tateno, Liang Liao, John R. Yates, III, Benjamin F. Cravatt, James C. Paulson
Mol Cell Proteomics. 2010 Jun; 9(6): 1339–1351. Published online 2010 Feb 19. doi: 10.1074/mcp.M900461-MCP200
PMCID:
PMC2877991
AbstractArticlePDF–803K
15.
The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound
Soerge Kelm, Judith Gerlach, Reinhard Brossmer, Claus-Peter Danzer, Lars Nitschke
J Exp Med. 2002 May 6; 195(9): 1207–1213. doi: 10.1084/jem.20011783
PMCID:
PMC2193707
AbstractArticlePDF–292K
16.
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency
Sarah Aminov, Orsi Giricz, David T. Melnekoff, R. Alejandro Sica, Veronika Polishchuk, Cristian Papazoglu, Bonnie Yates, Hao-Wei Wang, Srabani Sahu, Yanhua Wang, Shanisha Gordon-Mitchell, Violetta V. Leshchenko, Carolina Schinke, Kith Pradhan, Srinivas Aluri, Moah Sohn, Stefan K. Barta, Beamon Agarwal, Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, William Matsui, Ulrich Steidl, Joshua D. Brody, Nirali N. Shah, Samir Parekh, Amit Verma
J Clin Invest. 2024 Apr 15; 134(8): e175199. Published online 2024 Feb 20. doi: 10.1172/JCI175199
PMCID:
PMC11014656
AbstractArticlePDF–1.5M
17.
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
Shaun Cordoba, Shimobi Onuoha, Simon Thomas, Daniela Soriano Pignataro, Rachael Hough, Sara Ghorashian, Ajay Vora, Denise Bonney, Paul Veys, Kanchan Rao, Giovanna Lucchini, Robert Chiesa, Jan Chu, Liz Clark, Mei Mei Fung, Koval Smith, Carlotta Peticone, Muhammad Al-Hajj, Vania Baldan, Mathieu Ferrari, Saket Srivastava, Ram Jha, Frederick Arce Vargas, Kevin Duffy, William Day, Paul Virgo, Lucy Wheeler, Jeremy Hancock, Farzin Farzaneh, Sabine Domning, Yiyun Zhang, Nushmia Z. Khokhar, Vijay G. R. Peddareddigari, Robert Wynn, Martin Pule, Persis J. Amrolia
Nat Med. 2021; 27(10): 1797–1805. Published online 2021 Oct 12. doi: 10.1038/s41591-021-01497-1
PMCID:
PMC8516648
AbstractArticlePDF–7.9M
18.
N-Linked Glycosylation Regulates CD22 Organization and Function
Laabiah Wasim, Fathima Hifza Mohamed Buhari, Myuran Yoganathan, Taylor Sicard, June Ereño-Orbea, Jean-Philippe Julien, Bebhinn Treanor
Front Immunol. 2019; 10: 699. Published online 2019 Apr 4. doi: 10.3389/fimmu.2019.00699
PMCID:
PMC6458307
AbstractArticlePDF–5.3M
19.
CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
Edward A. Clark, Natalia V. Giltiay
Front Immunol. 2018; 9: 2235. Published online 2018 Sep 28. doi: 10.3389/fimmu.2018.02235
PMCID:
PMC6173129
AbstractArticlePDF–1011K
20.
Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man
Matthew S. Macauley, Norihito Kawasaki, Wenjie Peng, Shui-Hua Wang, Yuan He, Britni M. Arlian, Ryan McBride, Reiji Kannagi, Kay-Hooi Khoo, James C. Paulson
J Biol Chem. 2015 Dec 11; 290(50): 30066–30077. Published online 2015 Oct 27. doi: 10.1074/jbc.M115.691337
PMCID:
PMC4705971
AbstractArticlePDF–3.5M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center